INTRODUCTION {#S1}
============

SMD downregulates hundreds of human transcripts that regulate myogenesis^[@R1]^, cutaneous wound-healing^[@R2]^, adipogenesis^[@R3]^, and many if not most other cellular processes^[@R4]^. One of the first SMD targets identified was human *c-JUN* mRNA^[@R5]^, which encodes a protein that, together with c-FOS, forms the AP-1 early-response transcription factor^[@R6],[@R7]^. Since AP-1 regulates cell proliferation, differentiation, apoptosis, organogenesis and stress responses, SMD does also.

SMD is a translation-dependent process that targets mRNAs harboring a 3\' UTR SBS^[@R5],[@R8]^. SBSs can form intramolecularly, as best exemplified by the 19-base-pair stem and associated apex that typifies the 3\' UTR of mRNA encoding human ADP ribosylation factor 1 (ARF1)^[@R8]^. In support of its functional significance, this structure is conserved in the 3\' UTR of *ARF1* mRNA in rat and mouse^[@R8]^. SBSs can also form intermolecularly via base-pairing between the Alu element within the 3\' UTR of an SMD target and one or more partially complementary Alu elements within a long noncoding RNA (lncRNA), which we have called ½-sbsRNAs because they comprise one strand (i.e. half) of a double-stranded SBS^[@R2]^. As an example, the 3\' UTR Alu element within mRNA encoding CUB domain-containing protein 1 (CDCP1), which functions at the cell surface as an anti-apoptotic agent that promotes tumor-cell viability during or in early states of metastatic colonization^[@R9]^, is targeted for SMD upon base-pairing with the lncRNA we have named ½-sbsRNA2 (i.e., the second of those ½-sbsRNAs that we have studied)^[@R2]^. Alu elements are a type of short interspersed element (SINE) that are unique to primates, \~300 base-pairs in length, and constitute \~13% of the human genome^[@R10]^. Remarkably, B and identifier (ID) SINEs within lncRNAs of mouse, which we call m½-sbsRNAs, function analogously to Alu elements within ½-sbsRNAs of primates and trigger SMD despite the independent evolution of B and ID elements relative to Alu elements^[@R11]^.

SMD, like the mechanistically related pathway nonsense-mediated mRNA decay (NMD), involves the UPF1 RNA helicase^[@R4],[@R12]^. An SBS bound by STAU1 and/or is paralog STAU2^[@R13]^ is thought to function during SMD analogously to how a splicing-dependent exon-junction complex (EJC) functions during NMD: when translation terminates sufficiently upstream of either complex so that the terminating ribosome fails to displace the associated proteins, then mRNA decay will occur provided that the complex has acquired UPF1. STAU1 and STAU2 bind UPF1 directly during SMD^[@R13]^ as does the EJC constituent UPF2^[@R14],[@R15]^ or, in some cases, the EJC constituent UPF3X (also called UPF3B)^[@R1],[@R16],[@R17]^ during NMD. While studies of intermolecular SBSs have been restricted to sequences containing no more than two consecutive nucleotide mismatches, SBSs are apt to be more tolerant of mismatches given that their lengths can range from \~86--300 base-pairs^[@R2]^. Tolerance is also likely to be engendered by the ability of STAU1 and STAU2 to form homodimers and heterodimers, if not homomultimers and heteromultimers^[@R18],[@R19]^.

The finding that mRNA--lncRNA interactions occur in cells via Alu element base-pairing raised the intriguing issue of whether mRNA--mRNA interactions also occur in cells via Alu element base-pairing. Additionally, because only the mRNA strand of those mRNA--lncRNA duplexes studied to date is targeted for SMD, if mRNA--mRNA duplexes do form, would only one mRNA strand or would both mRNA strands be targeted for SMD?

In this communication, we computationally determine that 15,530,838 mRNA--mRNA duplexes potentially exist in human cells via intermolecular 3\' UTR Alu element base-pairing. We predict that a single mRNA can interact with multiple mRNAs via 3\' UTR Alu element base-pairing and demonstrate that mRNA--mRNA duplex formation can compete with mRNA--lncRNA duplex formation. Each mRNA of an mRNA--mRNA duplex is targeted for SMD provided that each is translated and that translation terminates sufficiently upstream of the SBS. We demonstrate the functional significance of mRNA--mRNA duplex formation in studies of mRNA encoding CUB domain-containing protein 1 (CDCP1), which functions at the cell surface as an anti-apoptotic agent that promotes tumor-cell viability during or in early states of metastatic colonization^[@R9]^. Our findings uncover a previously unappreciated function for mammalian-cell mRNAs. This function adds a new and unanticipated layer of complexity to the intricate network of post-transcriptional interactions that regulate human gene expression.

RESULTS {#S2}
=======

Computational predictions of human-cell mRNA--mRNA duplexes {#S3}
-----------------------------------------------------------

Of the 129,138 human transcripts reported in ENSEMBL, we determined that 3,943 contain a single 3\' UTR Alu element (RepeatMasker). We employed DuplexFold^[@R20]^ to obtain the predicted ΔG values of computationally derived mRNA--mRNA duplexes formed via base-pairing of partially complementary 3\' UTR Alu elements ([Supplementary Table 1](#SD1){ref-type="supplementary-material"}). Results revealed that duplexes between *bona fide* SMD targets were among the 15,530,838 duplexes obtained. Two of the *bona fide* SMD targets, *CDCP1* mRNA^[@R2]^ and Sosondowah ankyrin repeat domain family member C (*SOWAHC*) mRNA, formerly called *FLJ21870* mRNA^2^, are predicted to duplex via their 3\' UTR Alu elements with a ΔG value of −224 kcal/mol ([Fig. 1a](#F1){ref-type="fig"}, [Supplementary Fig. 1a, b](#SD3){ref-type="supplementary-material"} and [Supplementary Table 2](#SD2){ref-type="supplementary-material"}). siRNA to *SOWAHC* mRNA, which encodes a protein ([Supplementary Fig. 1c](#SD3){ref-type="supplementary-material"}) of unknown function, stimulates "wound healing" after scrape injury to keratinocyte monolayers as monitored by the migration rate of human keratinocyte HaCaT cells into a denuded wound track^[@R2]^. Intriguingly, upregulating CDCP1 protein also increases cell motility^[@R9]^. We hypothesized that if *CDCP1* mRNA--*SOWAHC* mRNA duplexes were to form, recruit STAU1 and trigger the SMD of each constituent mRNA, then downregulating *SOWAHC* mRNA would upregulate *CDCP1* mRNA. The resulting increase in CDCP1 protein would promote cell motility, since there is no evidence that SOWAHC protein affects cell motility ([Supplementary Fig. 1d](#SD3){ref-type="supplementary-material"}). The *CDCP1* mRNA 3\' UTR Alu element is also predicted to duplex with the 3\' UTR Alu element of another *bona fide* SMD target that encodes RAB11 family interacting protein 1 (RAB11FIP1) with a ΔG value of −251.2 kcal/mol ([Fig. 1a](#F1){ref-type="fig"}, [Supplementary Fig. 1a, b](#SD3){ref-type="supplementary-material"} and [Supplementary Table 2](#SD2){ref-type="supplementary-material"}). We hypothesized that downregulating *RAB11FIP1* mRNA would likewise upregulate the abundance of *CDCP1* mRNA. However, since RAB11FIP1 protein has been shown to promote wound healing^[@R2]^, downregulating RAB11FIP1 protein may mask the promotion of wound-healing attributable to the upregulation of CDCP1 protein ([Supplementary Fig. 1d](#SD3){ref-type="supplementary-material"}).

*SOWAHC* mRNA reduces the levels of predicted mRNA partners {#S4}
-----------------------------------------------------------

In tests of these hypotheses, downregulating the cellular abundance of either *SOWAHC* or *RAB11FIP1* mRNA to \~10-fold below normal indeed increased the level of *CDCP1* mRNA to \~2-fold above normal ([Fig. 1b](#F1){ref-type="fig"} and [Supplementary Fig. 1e, f](#SD3){ref-type="supplementary-material"}). As expected since each is an SMD target, the level of *SOWAHC*, *RAB11FIP1* or *CDCP1* mRNA was increased above normal by either *STAU1* or *UPF1* siRNA ([Fig. 1b, c](#F1){ref-type="fig"} and [Supplementary Fig. 1e, f](#SD3){ref-type="supplementary-material"}). The reduction in *CDCP1* mRNA abundance by *SOWAHC* mRNA is attributable to *SOWAHC* 3\' UTR sequences: a comparable level of an exogenous source of this 3\' UTR (i.e., expressing the plasmid pFLUC-SOWAHC 3\' UTR, which encodes mRNA harboring the firefly luciferase (FLUC) open translational reading frame upstream of the *SOWAHC* 3\' UTR) decreased the level of *CDCP1* mRNA ([Fig. 1d](#F1){ref-type="fig"} and [Supplementary Fig. 1g, h](#SD3){ref-type="supplementary-material"}). This decrease was eliminated when the abundance of cellular *SOWAHC* mRNA was reduced ([Fig. 1d](#F1){ref-type="fig"} and [Supplementary Fig. 1g, h](#SD3){ref-type="supplementary-material"}). In contrast, an exogenous source of *SOWAHC* 3\' UTR that lacks the Alu element (i.e., expressing the plasmid pFLUC-SOWAHC 3\' UTR(ΔAlu)) failed to decrease the level of *CDCP1* mRNA ([Fig. 1d](#F1){ref-type="fig"} and [Supplementary Fig. 1g, h](#SD3){ref-type="supplementary-material"}).

Computational analyses indicated that the 3\' UTR Alu element of *SOWAHC* mRNA could additionally base-pair with the 3\' UTR Alu element of mRNA encoding the phosphorylated glycoprotein tuftelin1 (TUFT1) as well as the 3\' UTR Alu element of mRNA encoding cyclosporin-binding enzyme peptidylprolyl isomerase D (PPID, also called cyclophilin D) with predicted ΔG values of −439.4 kcal/mol and −207.3 kcal/mol, respectively. The 3\' UTR Alu element of *RAB11FIP1* mRNA is predicted to do likewise with ΔG values of −434.6 kcal/mol and −307.4 kcal/mol, respectively ([Fig. 1a](#F1){ref-type="fig"}, [Supplementary Fig. 1a, b](#SD3){ref-type="supplementary-material"} and [Supplementary Table 2](#SD2){ref-type="supplementary-material"}). Remarkably, downregulation of either *SOWAHC* or *RAB11FIP1* mRNA increased the levels of *TUFT1* and *PPID* mRNAs to 2.5--3-fold above normal ([Fig. 1b](#F1){ref-type="fig"} and [Supplementary Fig. 1e, f](#SD3){ref-type="supplementary-material"}). These increases were attributable to SMD because downregulating either STAU1 or UPF1 increased the levels of *TUFT1* and *PPID* mRNAs to 2-2.5-fold above normal ([Fig. 1b, c](#F1){ref-type="fig"} and [Supplementary Fig. 1e, f](#SD3){ref-type="supplementary-material"}). Furthermore, these increases were mediated by the *SOWAHC* 3\' UTR Alu element ([Fig. 1d](#F1){ref-type="fig"} and [Supplementary Fig. 1g, h](#SD3){ref-type="supplementary-material"}).

It should be noted that while the 3\' UTR Alu element of *SERPINE1* mRNA is predicted to form a duplex with the 3\' UTR Alu element of *CDCP1*, *TUFT1* and *PPID* mRNAs ([Supplementary Fig. 1a](#SD3){ref-type="supplementary-material"}) with ΔG values of −137.6 kcal/mol, −100.7 kcal/mol and −74.1 kcal/mol, respectively ([Supplementary Fig. 1b](#SD3){ref-type="supplementary-material"}), only the level of *PPID* mRNA was increased when the level of *SERPINE1* mRNA was decreased. Thus, ΔG values alone are insufficient indicators of cellular base-pairing. For example, while *BAG5* mRNA and *CDCP1* mRNA are predicted to duplex with the lncRNA ½-sbsRNA2 with ΔG values of −416 kcal/mol and −513.7 kcal/mol, respectively^[@R9]^, only *CDCP1* mRNA is targeted for SMD in HeLa cells because *BAG5* mRNA fails to bind ½-sbsRNA2 (and undoubtedly other ½-sbsRNAs that are computationally predicted to base-pair with *BAG5* mRNA) and, thus, STAU1^[@R2],[@R21]^. Furthermore, each of two 30-nucleotide 3\' UTR sequences that perfectly base-pair with an artificial ½-sbsRNA trigger SMD when situated 74-nucleotides downstream of a termination codon but not when situated 44-nucleotides downstream of the same termination codon ([Supplementary Fig. 1i--n](#SD3){ref-type="supplementary-material"}). By analogy to the rule establishing which termination codons trigger NMD based on their distance from a downstream exon-junction complex^[@R12],[@R22]^, our results suggest that the 30-nucleotide SBSs must reside a minimum distance (\> 44 nucleotides) downstream of a termination codon to trigger SMD. Thus, multiple factors determine whether a potential mRNA--mRNA duplex will target either constituent mRNA for SMD (see also below).

mRNA--mRNA duplexes create SBSs {#S5}
-------------------------------

If an SBS could be formed by the 3\' UTR Alu element of *SOWAHC* mRNA base-pairing with the 3\' UTR Alu element of *CDCP1*, *TUFT1* or *PPID* mRNA, then it should be possible to co-immunoprecipitate the respective mRNA--mRNA complexes. To test this possibility, HeLa cells that transiently expressed two plasmid DNAs were crosslinked using formaldehyde so that only *bona fide* cellular complexes would be examined. The first plasmid encoded either FLUC-SOWAHC 3\' UTR-MS2bs mRNA, which contains 12 copies of the MS2 coat-protein binding site (MS2bs) upstream of the FLUC-SOWAHC 3\' UTR polyadenylation signal or, as negative controls, FLUC-MS2bs mRNA or FLUC-SOWAHC 3\' UTR mRNA ([Fig. 2a](#F2){ref-type="fig"}); the second plasmid encoded Flag-MS2-hMGFP protein, which consists of the MS2 coat-protein tagged with the Flag epitope and fused to monster green fluorescent protein (hMGFP)^[@R2]^. A fraction of each lysate was then immunoprecipitated using anti-Flag antibody. Prior to IP, when compared to FLUC-MS2bs mRNA expression, FLUC-SOWAHC 3\' UTR mRNA or FLUC-SOWAHC 3\' UTR-MS2bs mRNA expression decreased the abundance of *CDCP1*, *TUFT1* and *PPID* mRNAs without affecting the level of other SMD targets such as *SERPINE1* mRNA ([Fig. 2b](#F2){ref-type="fig"}).

In support of the concept that the 3\' UTR Alu element of *SOWAHC* mRNA forms an SBS through intermolecular base-pairing with the 3\' UTR Alu element of *CDCP1*, *TUFT1* or *PPID* mRNA, retrieval of the *SOWAHC* 3\' UTR from lysates of cells expressing FLUC-SOWAHC 3\' UTR-MS2bs mRNA using the anti-Flag antibody also immunoprecipitated cellular STAU1, STAU2 and UPF1 and cellular *CDCP1*, *TUFT1* and *PPID* mRNAs ([Fig. 2c](#F2){ref-type="fig"}). This did not occur in lysates expressing FLUC-SOWAHC 3\' UTR mRNA, FLUC-MS2bs mRNA ([Fig. 2b](#F2){ref-type="fig"}) or FLUC-SOWAHC 3\' UTR(ΔAlu)-MS2bs mRNA ([Fig. 2c](#F2){ref-type="fig"}), from which the *SOWAHC* 3\' UTR could not be retrieved. Results obtained in a "rescue" experiment also suggested that mRNA--mRNA duplexes form via base-pairing between complementary 3\' UTR Alu elements ([Supplementary Fig. 2a--c](#SD3){ref-type="supplementary-material"}): Retrieval of the FLUC-SOWAHC 3\' UTR-MS2bs mRNA using the anti-Flag antibody immunoprecipitated RLUC-PPID 3\' UTR mRNA but not RLUC-PPID 3\' UTR(AluR) mRNA, in which exclusively the 3\' UTR Alu element of *PPID* mRNA was in reversed orientation; however, RLUC-PPID 3\' UTR(AluR) mRNA could be retrieved using FLUC-SOWAHC 3\' UTR(AluR)-MS2bs mRNA, the latter of which also harbored exclusively its 3\' UTR Alu element in reversed orientation. Notably, STAU2, which is a paralog of STAU1, also functions in SMD^[@R13]^. Calnexin, protein kinase RNA-activated (PKR) and *SERPINE1* mRNA, which are irrelevant, were not detectably immunoprecipitated under any condition tested ([Fig. 2b, c](#F2){ref-type="fig"}). Furthermore, downregulating STAU1 decreased the co-IP of *CDCP1*, *TUFT1* and *PPID* mRNAs with FLUC-SOWAHC 3\' UTR-MS2bs mRNA ([Fig. 2d](#F2){ref-type="fig"}), indicating that STAU1 stabilizes the mRNA--mRNA complexes. In agreement with formaldehyde-crosslinking results, compared to cells that were untreated, mRNA--mRNA base-pairing between complementary 3\' UTR Alu elements was enhanced using cells treated with psoralen ([Supplementary Fig. 2d, e](#SD3){ref-type="supplementary-material"}), which forms covalent RNA--RNA crosslinks between two adjacent pyrimidine bases that are situated on opposite strands of dsRNA^[@R23]^.

mRNA--mRNA duplexes trigger SMD {#S6}
-------------------------------

To determine if the reduction in mRNA abundance brought about by the observed mRNA--mRNA duplexes triggers mRNA decay, cells transiently expressing pTRE-FLUC-SOWAHC 3\' UTR, which produces FLUC-SOWAHC 3\' UTR mRNA from a doxycycline-repressible promoter, in the presence of one of several siRNAs ([Fig. 3a](#F3){ref-type="fig"}) were harvested 30, 45, 60 or 75 min after doxycycline treatment. Compared to Control siRNA, siRNAs that downregulated STAU1 or UPF1 or *CDCP1*, *TUFT1* or *PPID* mRNA significantly increased the half-life of FLUC-SOWAHC 3\' UTR mRNA ([Fig. 3b](#F3){ref-type="fig"} and [Supplementary Fig. 3a, b](#SD3){ref-type="supplementary-material"}) as well as the abundance of FLUC-SOWAHC 3\' UTR mRNA and *RAB11FIP1* mRNA ([Fig. 3a](#F3){ref-type="fig"}).

SMD targets only translated strand(s) of mRNA--mRNA duplexes {#S7}
------------------------------------------------------------

To date, only the mRNA strand of an mRNA--lncRNA (i.e. an mRNA--½-sbsRNA) duplex has been found to be targeted for SMD^[@R2]^, possibly, we hypothesized, because only the mRNA in the duplexes studied is translationally active^[@R2],[@R24]^. However, this generalization is complicated by the finding that some transcripts that have been designated as lncRNAs footprint with ribosomes, suggesting that their short open reading frames might be translated^[@R25]^. Nevertheless, data suggest that the RNP structures of our lncRNAs differ in uncharacterized ways from those of mRNAs even though both are largely cytoplasmic. Nine-in-ten siRNAs chosen to downregulate an mRNA are generally successful, and the degree of downregulation is to \~10% of normal; however, only one-in-ten siRNAs chosen to downregulate an lncRNA is generally successful, and the degree of downregulation is to only \~50% of normal^[@R11]^ (data not shown). To determine the fate of mRNA--mRNA duplexes in which one mRNA is translationally active and the other is not, HeLa cells stably expressing IRE-Gl mRNA^[@R26]^ and transiently expressing (i) FLUC-AS 3\' UTR mRNA or FLUC mRNA, (ii) Control, *UPF1*, *STAU1* or *Gl* siRNA, and (iii) the reference MUP mRNA were cultured in the presence of either hemin or deferoxamine mesylate (Df) for 18-h prior to harvesting. IRE-Gl mRNA harbors the 35-nucleotide iron-responsive element (IRE) of ferritin mRNA in its 5\' UTR^[@R26]^, and the 3\' UTR of FLUC-AS 3\' UTR mRNA contains 66 nucleotides that perfectly duplex with 3\' UTR nucleotides in IRE-Gl mRNA ([Fig. 4a](#F4){ref-type="fig"}).

As expected IRE-Gl mRNA was translationally active in the presence of hemin, but translationally inactive in the presence of Df ([Supplementary Fig. 4a](#SD3){ref-type="supplementary-material"}), as was ferritin mRNA ([Fig. 4b](#F4){ref-type="fig"}). In contrast, FLUC-AS 3\' UTR mRNA was constitutively translated ([Fig. 4b](#F4){ref-type="fig"}). The level of FLUC mRNA was unaffected by hemin, Df or any siRNA ([Supplementary Fig. 4b](#SD3){ref-type="supplementary-material"}). The levels of FLUC-AS 3\' UTR mRNA and its product protein were likewise constant in the presence of either hemin or Df, but elevated 2-3-fold in the presence of *STAU1*, *UPF1* or *Gl* siRNA ([Fig. 4b, c](#F4){ref-type="fig"} and [Supplementary Fig. 4b, c](#SD3){ref-type="supplementary-material"}) indicating that it is targeted for SMD regardless of the translational status of IRE-Gl mRNA. Compared to Df, hemin decreased the level of IRE-Gl mRNA in the presence of Control siRNA, suggesting that IRE-Gl mRNA translation is required for its own SMD ([Fig. 4d](#F4){ref-type="fig"} and [Supplementary Fig. 4b, c](#SD3){ref-type="supplementary-material"}). Consistent with this interpretation, in the presence of hemin, the level of IRE-Gl mRNA after *STAU1* or *UPF1* siRNA treatment, compared to Control siRNA treatment, was upregulated \~2-fold ([Fig. 3d](#F3){ref-type="fig"} and [Supplementary Fig. 4b, c](#SD3){ref-type="supplementary-material"}), i.e., was upregulated when the level of FLUC-AS 3\' UTR mRNA was upregulated by either *STAU1* or *UPF1* siRNA treatment ([Fig. 4c](#F4){ref-type="fig"} and [Supplementary Fig. 4b, c](#SD3){ref-type="supplementary-material"}). As expected, the level of IRE-Gl mRNA was downregulated in the presence of either hemin or Df and the presence of *Gl* siRNA ([Fig. 4d](#F4){ref-type="fig"} and [Supplementary Fig. 4b, c](#SD3){ref-type="supplementary-material"}). Thus, translationally active IRE-Gl mRNA, unlike translationally inactive IRE-Gl mRNA, is an SMD target by virtue of its base-pairing with FLUC-AS 3\' UTR mRNA. We conclude that when an mRNA--mRNA duplex creates an SBS via base-pairing between complementary 3\' UTR sequences, each constituent mRNA is targeted for SMD provided that it is translated and the SBS resides sufficiently downstream of the termination codon.

SMD of mRNA--mRNA duplexes is functionally important {#S8}
----------------------------------------------------

We next examined the biological relevance of the complex web of mRNA--mRNA duplexes that are SMD targets using a trans-well^[@R9]^ assay to measure the migration and invasion indices of human pancreatic adenocarcinoma BxPC3 cells after introducing one or more siRNAs. Additionally, cell migration rates were assessed using human keratinocyte HaCaT cells in a wound-healing, also called or scrape-injury, assay^[@R9]^. As expected^[@R9]^, downregulating CDCP1 protein inhibited cell migration and invasion ([Fig. 5](#F5){ref-type="fig"}, [Supplementary Fig. 5](#SD3){ref-type="supplementary-material"}). Additionally, downregulating *SOWAHC* mRNA promoted cell migration and invasion ([Fig. 5](#F5){ref-type="fig"}, [Supplementary Fig. 5](#SD3){ref-type="supplementary-material"}). To test the hypothesis that downregulating *SOWAHC* mRNA promotes cell migration and invasion by inhibiting the SMD of *CDCP1* mRNA, we assessed the phosphorylation status of CDCP1 and PKCδ proteins using antibody to either phospho-(Tyr^734^)CDCP1 or phospho-(Tyr^311^)PKCδ. CDCP1 protein is known to undergo autophosphorylation, the level of which increases with an increase in CDCP1 protein cellular abundance^[@R9]^. Once autophosphorylated, CDCP1 protein binds PKCδ protein, resulting in an increased level of PKCδ phosphorylation that promotes cell motility^[@R9]^. In support of our hypothesis, downregulating *SOWAHC* mRNA was found to augment the degree of CDCP1 and PKCδ phosphorylation ([Fig. 5a](#F5){ref-type="fig"}). Furthermore, downregulating *SOWAHC* mRNA failed to increase the level of PKCδ phosphorylation or promote cell migration and invasion in the presence of *CDCP1* siRNA ([Fig. 5a, b](#F5){ref-type="fig"}).

DISCUSSION {#S9}
==========

Mammalian-cell mRNAs have long been known to constitute the intermediate between the DNA from which they are synthesized and the proteins that they encode. Recently, mRNAs have been shown to crosstalk with other mRNAs by serving as competing endogenous RNAs (ceRNAs), also called target mimics, that "sponge up" microRNAs, thus minimizing the microRNA-mediated downregulation of other target mRNAs^[@R27]--[@R31]^. Here we report a new and unanticipated physiologically important function for mRNAs: the SMD of one or more translationally active mRNAs that base-pair via partially complementary 3\' UTR Alu elements. When both mRNAs of such an mRNA--mRNA duplex are translationally active, then each is at once regulated and regulator since both are subjected to SMD.

The decay of a particular mRNA--mRNA duplex can in theory be fine-tuned by many variables. Variables include changes in the cytoplasmic abundance and/or translational state of one or both of the constituent mRNAs. Additionally, an increase or decrease in the number of mRNAs or lncRNAs that compete with mRNA--mRNA duplex formation, mRNA--mRNA duplex maintenance, or both could fine-tune decay. It should be noted that even though levels of the six mRNAs studied in this report are comparable to each other ([Supplementary Fig. 1e](#SD3){ref-type="supplementary-material"}), there is no need for these mRNAs to be in equal proportions to exert regulation of one another. Another possible means of regulation is alternative polyadenylation site usage, which could either maintain or remove a 3\' UTR Alu element that is required for mRNA--mRNA duplex formation. Alternative polyadenylation site usage affects the transcripts of more than half of human genes and is highly regulated depending on tissue-type and/or proliferation/differentiation state^[@R32],[@R19]^.

It is becoming clear that human cells have usurped 3\' UTR Alu elements for a multitude of regulatory purposes. Studies of a newly discovered type of regulation by intramolecular base-pairing between inverted repeat 3\' UTR Alu elements (3\' UTR IR*Alu*s) has revealed that STAU1 binding to 3\' UTR IR*Alu*s competes with binding of other dsRNA-binding proteins -- p54^nrb^ within nuclei, and protein kinase R (PKR) within the cytoplasm -- so as to preclude p54^nrb^-mediated nuclear retention in paraspeckles, and also PKR-mediated translational repression in the cytoplasm^[@R33]^. Given the overlap with which dsRNA-binding proteins recognize duplexes formed by base-pairing between 3\' UTR Alu elements, it will be interesting to determine how dsRNA-binding proteins other than STAU1 and STAU2 recognize and influence the metabolism of mRNA--mRNA duplexes.

ONLINE METHODS {#S10}
==============

Computational analyses {#S11}
----------------------

Two files, "Homo_sapien_GRCh37.62.cdna.all.fa", which contains the sequence of each transcript, and "Homo_sapien_GRCh37.62.gft", which contains splicing site(s) and coding region information for each human transcript, were downloaded from ENSEMBL ([www.ensembl.org](http://www.ensembl.org)). The 3\' UTR sequences were extracted and applied to RepeatMasker ([www.repeatmasker.org](http://www.repeatmasker.org)) to identify 3\' UTR Alu element(s). The DuplexFold function of RNAstructure (<http://rna.urmc.rochesterledu/RNAstructure.html>) was used to computationally predict the ΔG of derived human mRNA--mRNA duplexes formed via base-pairing of partially complementary 3\' UTR Alu elements. Intermolecular duplexes between the 3\' UTR Alu elements of specific mRNAs were computationally predicted using the Perl program "RNA_RNA_anneal"^[@R2]^.

Plasmid Constructions {#S12}
---------------------

To construct pFLUC-SOWAHC 3\' UTR(ΔAlu), pFLUC-SOWAHC 3\' UTR^[@R2]^, which contains the complete 3\' UTR of *SOWAHC* mRNA, was PCR-amplified using two sets of primer pairs: 5\'-GAGTCA[AAGCTT]{.ul}ATGGAAGACGCCAAAAACATAAAG-3\' (sense A) and 5\'-CATTCATCTTTCATCCATCTTTAAACAAATTC-3\' (antisense A), and 5\'-GGATGAAAGATGAATGAAAATATGAAATATATAAAC-3\' (sense B) and 5\'-GTCA[GGGCCC]{.ul}TTTCACAAAACAAACTTTACAGATTTTACAATCTCCC-3\' (antisense B), where underlined nucleotides specify HindII and ApaI, respectively. The resulting two PCR products were mixed and PCR-amplified using the sense A and antisense B primer pair. This PCR product was cleaved with HindIII and ApaI and subsequently inserted into HindIII- and ApaI-cleaved pFLUC.

To construct pFLUC-SOWAHC 3\' UTR -MS2bs or pFLUC-SOWAHC 3\' UTR(ΔAlu)-MS2bs, pFLUC-SOWAHC 3\' UTR or pFLUC-SOWAHC 3\' UTR(ΔAlu) was PCR-amplified using the primer pair 5\'- GAGTCA[AAGCTT]{.ul}ATGGAAGACGCCAAAAACATAAAG-3\' (sense) and 5\'- GTCA[GGATCC]{.ul}GAGACAGAGTCTCCGTTGCCCAGG-3\' (antisense), where underlined nucleotides denote a HindIII or BamHI site, respectively. The resulting PCR products were cleaved using HindIII and BamHI and subsequently inserted into HindIII- and BamHI-cleaved pFLUC-MS2bs^[@R2]^.

To construct pFLUC-AS 3\' UTR, pFLUC was PCR-amplified using two sets of primer pairs: 5\'-GAGTCA[AAGCTT]{.ul}ATGGAAGACGCCAAAAACATAAAG-3\' (sense C) and 5\'-CTTCATAATATCCCCCAGTTTAGTAGTTGGACTTAGGGAACTAATAAAATGAGGAAA TTGCATCGC-3\' (antisense C), and 5\'-TGGGGGATATTATGAAGGGCCTTGAGCATCTGGATTCTGCCATGGCTGGCAACTAGA AGGCACAG-3\' (sense D) and 5\'-GTCA[CCTAGG]{.ul}CCTCCAAAAAAGCCTCCTCACTAC-3\' (antisense D). The resulting two PCR products were mixed and PCR-amplified using the sense C and antisense D primer pair. This PCR product was cleaved with HindIII and AvrII and subsequently inserted into HindIII- and AvrII-cleaved pFLUC.

To construct pTRE-FLUC-SOWAHC 3\' UTR, FLUC-SOWAHC 3\' UTR was PCR-amplified using pFLUC-SOWAHC 3\' UTR and the primer pair 5\'-GAGTCA[AAGCTT]{.ul}ATGGAAGACGCCAAAAACATAAAG-3\' (sense) and 5\'-GTCA[GAATTC]{.ul}GAGACAGAGTCTCCGTTGCCC-3\' (antisense), where underlined nucleotides denote a SacII or EcoRI site, respectively. The resulting PCR product was digested with SacII and EcoRI and subsequently inserted into SacII- and EcoRI-cleaved pTRE (Clontech).

To construct pFLUC-SOWAHC 3\' UTR(AluR)-MS2bs, in which specifically the Alu element was present in reverse orientation (R), pFLUC-SOWAHC 3\' UTR-MS2bs was PCR-amplified using three sets of primer pairs to generate PCR products E, F and G, respectively: 5\'-CTTAATTTTCC[AAGCTT]{.ul}TTCTTGAC-3\' (sense E) and 5\'-TTTCATCCATCTTTAAACAAATTCAATGACC-3\' (antisense E), 5\'-CATATTTTCATTCATCGGCCAGGCATGGTGGCTCATGCC-3\' (sense F) and 5\'-GTTTAAAGATGGATGAAATTTTTTTTTTTTTTTTTTGAGACAGAGTCTCCGTTGCCC-3\' (antisense F), and 5\'-GATGAATGAAAATATGAAATATATAAAC-3\' (sense G) and 5\'-CAGTGGGAAAA[CCATGG]{.ul}TAAATGAC-3\' (antisense G). PCR products E and F were mixed and PCR-amplified using the sense E and antisense F primer pair to generate PCR product EF. Then PCR products EF and G were mixed and PCR-amplified using the sense E and antisense G primer pair. This PCR product was cleaved with HindIII and NcoI and subsequently inserted into HindIII- and NcoI-cleaved pFLUC-SOWAHC 3\' UTR-MS2bs.

To construct pRLUC-PPID 3\' UTR, the complete 3\' UTR of *PPID* mRNA was amplified using HeLa-cell genomic DNA and primer pair: 5\'-GATG[TCTAGA]{.ul}GTGAAAAGGATTCAGTTTTGCTTATTGTGTG-3\' (sense) and 5\'-GTCA[GGGCCCC]{.ul}AATAAGATGTGTCTTTACAAGTTTAAAAAGACTGGACACC-3\' (antisense). The resulting PCR product was cleaved with XbaI and ApaI and subsequently inserted into XbaI- and ApaI-cleaved pRLUC^[@R19]^.

To construct pRLUC-PPID 3\' UTR(AluR), pRLUC-PPID 3\' UTR was PCR-amplified using three sets of primer pairs: 5\'-GATG[TCTAGA]{.ul}GTGAAAAGGATTCAGTTTTGCTTATTGTGTG-3\' (sense H) and 5\'-CCACTTTACTTACTGTATTGTGAC-3\' (antisense H), 5\'-CCATTTTAAAAAACATTTTACTTTTTTGTTTGTTTCTTTGAGATGGAG-3\' (sense I) and 5\'- ACAGTAAGTAAAGTGGGGCCGGGCACGGTGGCTCACACC-3\' (antisense I), and 5\'-AAGTAAAATGTTTTTTAAAATGG-3\' (sense J) and 5\'-GTCA[GGGCCCC]{.ul}AATAAGATGTGTCTTTACAAGTTTAAAAAGACTGGACACC-3\' (antisense J). PCR products H and I were mixed and PCR-amplified using the sense H and antisense I primer pair to get PCR product HI. Then HI and J were mixed and PCR-amplified using the sense H and antisense J primer pair. This PCR product was cleaved with XbaI and ApaI and subsequently inserted into XbaI- and ApaI-cleaved pRLUC-PPID 3\' UTR.

To construct pFLUC-artificial 3\' UTR (shuffle), pFLUC was PCR-amplified using two sets of primer pairs: 5\'-GAGTCA[AAGCTT]{.ul}ATGGAAGACGCCAAAAACATAAAG-3\' (sense K) and 5\'-GATGGCTGAAGGAAGGAGGACAGTGGGAGTGGCACCTTCCAGGGTCGCAACTAGAA GGCACAGTCGAGGC-3\' (antisense K), and 5\'-ACTGTCCTCCTTCCTTCAGCCATCTGTTGTTTGCCCCTCCCCCGTGTCCTAATAAAAT GAGGAAATTGCATCGC-3\' (sense L) and 5\'-GTCA[CCTAGG]{.ul}CCTCCAAAAAAGCCTCCTCACTAC-3\' (antisense L). The resulting two PCR products were mixed and PCR-amplified using the sense K and antisense L primer pair. This PCR product was cleaved with HindIII and AvrII and subsequently inserted into HindIII-and AvrII-cleaved pFLUC.

To construct (i) pAS lncRNA 1--68, (ii) pAS lncRNA 1--30 or (iii) pAS lncRNA39--68, p½-sbsRNA1(S)^[@R2]^ was PCR-amplified using two sets of primer pairs: (i) 5\'-GAGTCA[AAGCTT]{.ul}AAAGGAGAGACAGTCTCACTCTG-3\' (sense M) and 5\'-CCCCCGTGCCTTCCTTGACCCTGGAAGGTGCCACTCCCACTGTCCTACAAAGAAAAT TAAATTAGCAGGG-3\' (antisense N), and 5\'-CCAGGGTCAAGGAAGGCACGGGGGAGGGGCAAACAACAGATGGCTGTTAGGATTA CAGGAGTGAGCC-3\' (sense N) and 5\'-GTCA[GCGGCCGC]{.ul}CAGTTGTAAGCATATTTGGGTTAC-3\' (antisense M), (ii) 5\'-GAGTCA[AAGCTT]{.ul}AAAGGAGAGACAGTCTCACTCTG-3\' (sense M) and 5\'-GAAGGTGCCACTCCCACTGTCCTACAAAGAAAATTAAATTAGCAGGG-3\' (antisense O), and 5\'-TGGGAGTGGCACCTTCCAGGGTCTTAGGATTACAGGAGTGAGCC-3\' (sense O) and 5\'-GTCA[GCGGCCGC]{.ul}CAGTTGTAAGCATATTTGGGTTAC-3\' (antisense M), or (iii) 5\'-GAGTCA[AAGCTT]{.ul}AAAGGAGAGACAGTCTCACTCTG-3\' (sense M) and 5\'-CTGTTGTTTGCCCCTCCCCCGTGACAAAGAAAATTAAATTAGCAGGG-3\' (antisense P), and 5\'-GAGGGGCAAACAACAGATGGCTGTTAGGATTACAGGAGTGAGCC-3\' (sense P) and 5\'-GTCA[GCGGCCGC]{.ul}CAGTTGTAAGCATATTTGGGTTAC-3\' (antisense M). The resulting two PCR products were mixed and PCR-amplified using the corresponding sense M and antisense M primer pairs. Each PCR product was subsequently cleaved with HindIII and NotI and inserted into HindIII- and NotI-cleaved p½-sbsRNA1(S).

Cell culture, transient transfections, formaldehyde crosslinking, and mRNA half-life determinations {#S13}
---------------------------------------------------------------------------------------------------

Human HeLa cells, HeLa Tet-off cells (Clontech), HeLa cells stably expressing IRE-Gl Norm mRNA^[@R26]^, or HaCaT cells were grown in DMEM (Gibco-BRL) containing 10% fetal bovine serum (Gibco-BRL) at 37°C and in 5% CO~2~. Human BxPC3 cells (Sigma) were grown in RPMI 1640 (Gibco-BRL) containing 10% fetal bovine serum (Gibco-BRL). After reaching a density of 2 × 10^6^/60-mm dish or 7.5 × 10^7^/150-mm dish, cells were transiently transfected with the specified plasmids using Lipofectamine 2000 (Invitrogen) or the specified siRNA using Oligofectamine (Invitrogen) as described^[@R2]^. siRNAs consist of the nonspecific Silencer Negative Control \#1 (Ambion), *STAU1* siRNA^[@R2]^, *STAU1*(A) siRNA^[@R2]^, *UPF1* siRNA^[@R2]^, *UPF1*(A) siRNA^[@R2]^, *SERPINE1* siRNA (Ambion, cat\#: s10013), *SERPINE1*(A) siRNA (Ambion, cat\#: s10014), *SOWAHC* siRNA (Ambion, cat\#: s35230), *SOWAHC*(A) siRNA (Ambion, cat\#: s35231), *RAB11FIP1* siRNA (Ambion, cat\#: s37090), *RAB11FIP1* (A) siRNA (Ambion, cat\#: s37092), *CDCP1* siRNA (Ambion, cat\#: s35061), *CDCP1*(A) siRNA (Ambion, cat\#: s35062), *TUFT1* siRNA (Ambion, cat\#: s14508), *TUFT1*(A) siRNA (Ambion, cat\#: s14509), *PPID* siRNA (Ambion, cat\#: s10913), *PPID*(A) siRNA (Ambion, cat\#: s10915) and ½-sbsRNA1 siRNA^[@R2]^ ([Supplementary Table 4](#SD2){ref-type="supplementary-material"}). For all immunoprecipitations, cells were crosslinked using 1% formaldehyde for 10 min at room temperature and subsequently quenched with 0.25 M glycine for 5 min at room temperature prior to lysis using sonication and subsequently reversing the crosslinks by heating for 45 min at 65°C^[@R2]^. Alternatively, cells were crosslinked using psoralen^[@R23]^. Cells were washed with phosphate-buffered saline (PBS) twice and then incubated with 5μM psoralen (Sigma) in PBS for 10 min. A first round of psoralen crosslinking was achieved using 365nm UV light (1.2kJ/m^2^/min; UVP) for 5 min at room temperature, after which excess psoralen was removed by two sequential incubations in PBS at 37°C in 5% CO~2~ for 10 min. A second round of psoralen crosslinking was achieved in the presence of 365 nm UV light (1.2kJ/m^2^/min) for 15 min at room temperature. Cells were harvested as usual. For half-life measurements^[@R2]^, HeLa Tet-Off cells were transfected with the specified siRNA in the presence of 2 μg/ml of doxycycline and, after removing doxycycline 48-h later, were transfected with the pTRE-FLUC-SOWAHC 3\' UTR reporter plasmid, which contains a doxycycline-repressible promoter, and the phCMV-MUP reference plasmid. A fraction of cells was harvested after an additional 4-h (time 0), at which point 2 μg/ml of doxycycline was added to the remaining cells to block FLUC-SOWAHC 3\' UTR mRNA synthesis. Aliquots of cells were harvested at various times thereafter. HeLa cells stably expressing IRE-Gl Norm mRNA or IRE-Gl Ter mRNA were transfected with specified siRNA and, subsequently, the specified plasmids and cultured for one day after which 100 μM of deferoxamine mesylate (Sigma) was added. After 24 h, cells were washed with phosphate-buffered saline and subsequently cultured in fresh medium containing 100 μM of either deferoxamine mesylate or hemin (Sigma) for the specified time prior to lysis.

Protein purification, IP and western blotting {#S14}
---------------------------------------------

HeLa cells were lysed, and protein was isolated using hypotonic buffer that consists of 10mM Tris-Cl (pH 7.4), 150mM NaCl, 2mM EDTA, 0.5% Triton X-100, 2mM benzamidine, 1mM PMSF and 1 tablet of protease inhibitor cocktail (Roche). If crosslinked, cells were sonicated six times for 30 sec to facilitate lysis. IP was performed as described^[@R2]^. Western blotting was performed as outlined^[@R2]^. Antibodies consisted of anti-SOWAHC (Bethyl Laboratories, cat\#: A301-412A), anti-STAU1^[@R34]^, anti-UPF1^[@R11]^, anti-calnexin (StressGene, cat\#: SPA-860), anti-Flag (Sigma, cat\#: A8592), anti-ferritin (AbCam, cat\#: ab7332), anti-CDCP1 (Cell Signaling Technology, cat\#: 4115), anti-p(Tyr^734^)CDCP1 (Cell Signaling Technology, cat\#: 9050), anti-PKCδ (Cell Signaling Technology, cat\#: 2058), and anti-p(Tyr^311^)PKCδ (Cell Signaling Technology, cat\#: 2058). Western blot analyses situated under wedges in the leftmost lanes of figures utilized 3-fold dilutions of protein/cells lysate and show that data fall in the linear range.

RNA purification and RT coupled to either semiquantitative (sq) or realtime (q)PCR {#S15}
----------------------------------------------------------------------------------

RNA was purified from total-cell lysates or immunoprecipitated-cell lysates using TRIzol (Invitrogen) as reported^[@R2]^. RT-sqPCR and RT-qPCR were performed^[@R2]^ using the designated primer pairs ([Supplementary Table 3](#SD2){ref-type="supplementary-material"}). RT-sqPCR analyses situated under wedges in the leftmost lanes of figures utilized 2-fold dilutions of RNA and show that data fall in the linear range. RT-PCR values include standard error of measurements obtained in the specified number of independently performed experiments.

Scrape-injury and cell migration and invasion assays {#S16}
----------------------------------------------------

Scrape-injury repair assays were essentially as published^[@R2]^. Human BxPC3 cells (7.5 × 10^7^/150-mm dish) were treated with specified siRNA for 72 h, serum-starved for 6 h, and detached using trypsin-EDTA. Then, 1 × 10^5^ cells in 100 μl of RPMI 1640 were seeded onto either Falcon Cell Culture Inserts (BD Biosciences) for the migration assay or the upper part of a BD BioCoat Matrigel Invasion Chamber (BD Biosciences) for the invasion assay. After incubations of 6 h and 16 h, respectively, membrane-associated cells were fixed using methanol and stained using Toluidine blue (Sigma). The total number of migrated or invaded cells was determined by counting the cells that had moved from each of three wells through the membrane. Nine fields per membrane were evaluated using an Axiovert 40C inverted microscope (Zeiss).
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![*SOWAHC* mRNA reduces the abundance of mRNAs to which it is predicted to base-pair via partially complementary 3\' UTR Alu elements\
**a**, Diagram of computationally predicted putative mRNA--mRNA duplexes that form in human cells via base-pairing between partially complementary 3\' UTR Alu elements ([Supplementary Table S1](#SD1){ref-type="supplementary-material"}). **b**, Histogram representation of RT-sqPCR analyses of the indicated mRNA using lysates of HeLa cells treated with the specified siRNA (see [Supplementary Fig. 1o](#SD3){ref-type="supplementary-material"} for data using alternative siRNAs). The level of each mRNA was normalized to the level of *GAPDH* mRNA, and normalized levels in the presence of Control siRNA are defined as 100. Black arrows denote results that implicate mRNA--mRNA duplex formation. **c**, Western blot (WB) using the designated antibody and lysates analyzed in **c.** Calnexin serves as a loading control. **d**, Histogram representation of RT-sqPCR analyses of lysates of HeLa cells that had been transiently transfected with the specified siRNA and pFLUC-SOWAHC 3\' UTR, pFLUC-SOWAHC 3\' UTR(ΔAlu) or, as a negative control, pFLUC-No SBS. The level of each mRNA was normalized to the level of MUP mRNA (from the phCMV-MUP reference plasmid), and normalized levels in the presence of Control siRNA + pFLUC-No SBS are defined as 100. Error bars, s.e.m.; \# of independently performed experiments = 3; \*, P \< 0.05 (one-tail *t*-test).](nihms-514288-f0001){#F1}

![mRNA--mRNA duplexes create SBSs and trigger SMD\
**a**, Diagram of FLUC-SOWAHC 3\' UTR mRNA harboring 12 copies of MS2bs base-paired with *CDCP1*, *TUFT1* or *PPID* mRNA via complementary 3\' UTR Alu elements. **b**, Western blot (upper) or RT-sqPCR(lower) before (−) or after immunoprecipitation (IP) of lysates of formaldehyde-crosslinked HeLa cells that had been transiently transfected with pFlag-MS2-hMGFP and pFLUC-SOWAHC 3\' UTR, pFLUC-SOWAHC 3\' UTR-MS2bs or pFLUC-MS2bs. IP was performed using either anti-Flag or, as a control for nonspecific IP, mouse immunoglobulin G (mIgG). **c**, essentially as in **b** except pFLUC-SOWAHC 3\' UTR-MS2bs or pFLUC-SOWAHC 3\' UTR(ΔAlu)-MS2bs was used. **d**, essentially as in **b** except cells were transfected with Control or *STAU1* siRNA. Error bars, s.e.m.; \# of independently performed experiments = 3; P \< 0.05 (one-tail *t*-test).](nihms-514288-f0002){#F2}

![mRNA--mRNA duplexes create SBSs and trigger SMD\
**a**, Western blot (upper) or RT-sqPCR(lower) of lysates of HeLa Tet-Off cells that had been transiently transfected with the specified siRNA (see [Supplementary Fig. 3c](#SD3){ref-type="supplementary-material"} for data using alternative siRNAs) in the presence of 2 μg/ml of doxycycline (DOX) and, after removing doxycycline 48-h later, with pTRE-FLUC-SOWAHC 3\' UTR, which contains a doxycycline-repressible promoter, and the phCMV-MUP reference plasmid. The removal of DOX elicits a transcriptional burst in FLUC-SOWAHC 3\' UTR mRNA production. A fraction of cells was harvested after an additional 4-h (time 0) and analyzed. **b**, Plot of RT-sqPCR data using samples shown in **a** that were further processed as follows. At time 0, 2 μg/ml of doxycycline were added to the remaining cells. Additional fractions of cells were harvested at the specified times thereafter. RT-sqPCR analyses were essentially as in [Fig. 1b.](#F1){ref-type="fig"} As in [Fig. 1d](#F1){ref-type="fig"}, the levels of exogenous FLUC-SOWAHC 3\' UTR mRNAs were comparable to the level of cellular *SOWAHC* mRNA. Error bars, s.e.m.; \# of independently performed experiments = 3; P \< 0.05 (Chi-squared test).](nihms-514288-f0003){#F3}

![An mRNA that duplexes with another mRNA by 3\' UTR base-pairing is targeted for SMD provided it is translationally active\
**a**, Diagram of IRE-Gl mRNA base-paired with FLUC-AS 3\' UTR mRNA, which contains 3\' UTR sequences engineered to be complementary to 3\' UTR sequences of Gl mRNA. **b**, Western blot (WB) of lysates of HeLa cells stably expressing IRE-Gl mRNA and transiently expressing FLUC-AS 3\' UTR mRNA (+) or, as a negative control, FLUC mRNA (−), the specified siRNA, and the reference MUP mRNA. Cells were cultured in the presence of either hemin or deferoxamine mesylate (Df) for 18-h prior to harvesting. **c**, Histogram representations of RT-sqPCR analyses of samples analyzed in **b**. The level of FLUC-AS 3\' UTR mRNA was normalized to the level of MUP mRNA ([Supplementary Fig. 4b](#SD3){ref-type="supplementary-material"}), and the normalized level in the presence of Df and Control siRNA is defined as 100. **d**, as in **c**, but the level of IRE-Gl mRNA was normalized to the level of cellular *SMG7* mRNA ([Supplementary Fig. 4b](#SD3){ref-type="supplementary-material"}). Error bars, s.e.m.; \# of independently performed experiments = 3; \*, P \<0.05 (one-tail *t*-test).](nihms-514288-f0004){#F4}

![Evidence that the SMD of mRNA--mRNA duplexes contributes to pancreatic adenocarcinoma cell migration and invasion\
**a**, RT-sqPCR and Western blotting (WB) analyses of lysates of BxPC3 cells that had been transiently transfected with the specified siRNA(s). *GAPDH* mRNA and Calnexin represent loading controls. **b**, Migration and invasion assays of BxPC3 cells after transfection with the specified siRNA(s). **c**, Model for the mechanism by which siRNA to *SOWAHC* mRNA, which encodes a protein of unknown function, promotes BxPC3-cell migration and invasion: downregulating *SOWAHC* mRNA inhibits *SOWAHC* mRNA-*CDCP1* mRNA base-pairing and, thus, the *SOWAHC* mRNA-mediated SMD of *CDCP1* mRNA, which encodes a protein that inhibits cell migration and invasion. \# of independently performed experiments = 3, \*, P \<0.05 (one-tail *t*-test).](nihms-514288-f0005){#F5}
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